1. |
Al Arfaj AS, Khalil N. Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia.[J] Lupus, 2009, 18(5):465-473.
|
2. |
谭艳红, 刘冬舟, 肖学吕, 等. 自身免疫性疾病合并恶性肿瘤17例分析[J]. 临床和实验医学杂志, 2007, 6(3):41-42.
|
3. |
Bernatsky S, Ramsey-Goldman R, Clarke AE. Malignancy in systemic lupus erythematosus:what have we learned?[J]. Best Pract Res Clin Rheumatol, 2009, 23(4):539-547.
|
4. |
陈冬莹, 王晓东, 詹钟平, 等. 硫唑嘌呤治疗系统性红斑狼疮的不良反应与硫嘌呤甲基转移酶活性的关系[J]. 中山大学学报·医学科学版, 2011, 32(6):777-780, 785.
|
5. |
Anderson LA, Pfeiffer RM, Landgren O, et al. Risks of myeloid malignancies in patients with autoimmune conditions[J]. Br J Cancer, 2009, 100(5):822-828.
|
6. |
Kittang AO, Hatfield K, Sand K, et al. The chemokine network in acute myelogenous leukemia:molecular mechanisms involved in leukemogenesis and therapeutic implications[J]. Curr Top Microbiol Immunol, 2010, 341:149-172.
|
7. |
Hase K, Tani K, Shimizu T, et al. Increased CCR4 expression in active systemic lupus erythematosus[J]. J Leukoc Biol, 2001, 70(5):749-755.
|
8. |
刘佳, 钟璐, 朱坚轶, 等. 系统性红斑狼疮合并急性髓系白血病一例[J]. 白血病·淋巴瘤, 2012, 21(6):378-379.
|
9. |
Ziakas PD, Giannouli S, Zintzaras E, et al. Lupus thrombocytopenia:clinical implications and prognostic significance[J]. Ann Rheum Dis, 2005, 64(9):1366-1369.
|